Clinical Trial Update: TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

View source ↗

Summary

This post-approval study by Boston Scientific evaluates methods to calculate the radiation-absorbed dose of Tc-99m MAA when used with TheraSphere Y-90 glass mic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Hepatocellular Carcinoma | Status: COMPLETED | Results posted: 2025-03-06